Skip to main content

and
  1. No Access

    Article

    Doing it All - How Families are Resha** Rare Disease Research

    The face of rare disease drug discovery and development is changing right before our eyes. The outliers of the past were the plucky parents who summoned up the courage to try to treat their children against al...

    Sean Ekins, Ethan O. Perlstein in Pharmaceutical Research (2018)

  2. Article

    Open Access

    Anatomy of the Crowd4Discovery crowdfunding campaign

    Crowdfunding allows the public to fund creative projects, including curiosity-driven scientific research. Last Fall, I was part of a team that raised $25,460 from an international coalition of “micropatrons” f...

    Ethan O Perlstein in SpringerPlus (2013)

  3. Article

    Open Access

    Amino Acid Metabolic Origin as an Evolutionary Influence on Protein Sequence in Yeast

    The metabolic cycle of Saccharomyces cerevisiae consists of alternating oxidative (respiration) and reductive (glycolysis) energy-yielding reactions. The intracellular concentrations of amino acid precursors gene...

    Benjamin L. de Bivort, Ethan O. Perlstein, Sam Kunes in Journal of Molecular Evolution (2009)

  4. No Access

    Article

    Evolutionarily Conserved Optimization of Amino Acid Biosynthesis

    The “cognate bias hypothesis” states that early in evolutionary history the biosynthetic enzymes for amino acid x gradually lost residues of x, thereby reducing the threshold for deleterious effects of x scarcity...

    Ethan O. Perlstein, Benjamin L. de Bivort, Samuel Kunes in Journal of Molecular Evolution (2007)

  5. No Access

    Article

    Small molecules enhance autophagy and reduce toxicity in Huntington's disease models

    Sovan Sarkar, Ethan O Perlstein, Sara Imarisio, Sandra Pineau in Nature Chemical Biology (2007)

  6. No Access

    Article

    Genetic basis of individual differences in the response to small-molecule drugs in yeast

    Individual response to small-molecule drugs is variable; a drug that provides a cure for some may confer no therapeutic benefit or trigger an adverse reaction in others. To begin to understand such differences...

    Ethan O Perlstein, Douglas M Ruderfer, David C Roberts in Nature Genetics (2007)

  7. No Access

    Article

    Microarray-based method for monitoring yeast overexpression strains reveals small-molecule targets in TOR pathway

    Identification of the cellular targets of small-molecule hits in phenotypic screens is a central challenge in the development of small molecules as biological tools and potential therapeutics. To facilitate th...

    Rebecca A Butcher, Bhupinder S Bhullar, Ethan O Perlstein in Nature Chemical Biology (2006)

  8. Article

    Open Access

    Global nucleosome occupancy in yeast

    Although eukaryotic genomes are generally thought to be entirely chromatin-associated, the activated PHO5 promoter in yeast is largely devoid of nucleosomes. We systematically evaluated nucleosome occupancy in ye...

    Bradley E Bernstein, Chih Long Liu, Emily L Humphrey, Ethan O Perlstein in Genome Biology (2004)